Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages

被引：4
|
作者：
Ly, Andrew [1 ]
Sanber, Khaled [2 ]
Tsai, Hua-Ling [2 ]
Ondo, Angela [2 ]
Mooney, Kathy [2 ]
Shedeck, Audra [2 ]
Baker, Julie [2 ]
Imus, Philip Hollingsworth [2 ]
Wagner-Johnston, Nina [2 ]
Jain, Tania [2 ,3 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies & Bone Marrow Transplanta, Baltimore, MD USA
[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies & Bone Marrow Transplanta, 1650 Orleans St,Room 3M88, Baltimore, MD 21287 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 203卷 / 04期
关键词：
D O I：
10.1111/bjh.19090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：688 / 692
页数：5
相关论文
共 50 条
  • [41] Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?
    de la Asuncion, Carlos Solano
    Hernani, Rafael
    Albert, Eliseo
    Gomez, Maria Dolores
    Gimenez, Estela
    Benzaquen, Ana
    Gonzalez-Barbera, Eva Maria
    Hernandez-Boluda, Juan Carlos
    Perez, Ariadna
    Pinana, Jose Luis
    Chorao, Pedro
    Guerreiro, Manuel
    Montoro, Juan
    Sanz, Jaime
    Solano, Carlos
    Navarro, David
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (08) : 1093 - 1095
  • [42] Bone Marrow Lymphoid Infiltrates and Aplasia after CD19-Directed CAR T Cell Therapy in Pediatric BLymphoblastic Leukemia
    McFerran, Jared
    Lytle, Andrew
    Gebre, Kirubel
    Pillai, Vinodh
    BLOOD, 2021, 138
  • [43] EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort Study
    Korell, Felix
    Penack, Olaf
    Mattie, Mike
    Schreck, Nicholas
    Benner, Axel
    Krzykalla, Julia
    Wang, Zixing
    Schmitt, Michael
    Bullinger, Lars
    Mueller-Tidow, Carsten
    Dreger, Peter
    Luft, Thomas
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Early real-world experience with CD19-directed chimeric antigen receptor T-cell therapy (CAR T) among patients with diffuse large B-cell lymphoma (DLBCL)
    Jalbert, Jessica J.
    Arnason, Jon E.
    Ge, Wenzhen
    Chen, Chieh-I
    Ambati, Srikanth
    Wu, Ning
    Chaudhry, Aafia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 113 - 113
  • [45] Phase 2 open label, multicenter study evaluating CRG-022, a CD22-directed autologous CAR T-cell therapy, in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after CD19-directed CAR T-cell therapy.
    Ghobadi, Armin
    Jacobson, Caron Alyce
    McGuirk, Joseph
    Shah, Nirali
    Rossi, John
    Buchholz, Tonia Jane
    Bachier-Rodriguez, Lizamarie
    Baird, John H.
    Diefenbach, Catherine S.
    Farooq, Umar
    Hernandez-Ilizaliturri, Francisco J.
    Isufi, Iris
    Patel, Krish
    Neelapu, Sattva Swarup
    Sauter, Craig Steven
    Spiegel, Jay Y.
    Tees, Michael Timothy
    Timmerman, John
    Laport, Ginna
    Frank, Matthew Joshua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma
    Jalbert, Jessica J.
    Wu, Ning
    Chen, Chieh-, I
    Ambati, Srikanth
    Ge, Wenzhen
    Arnason, Jon E.
    ADVANCES IN THERAPY, 2022, 39 (06) : 2630 - 2640
  • [47] Tumor gene expression signatures associated with outcome in large B-cell lymphoma treated with CD19-directed CAR T-cell therapy (axicabtagene ciloleucel)
    Tian, Yuan
    Budka, Justin
    Locke, Frederick L.
    Westin, Jason R.
    To, Christina
    Tiwari, Gayatri
    Mao, Daqin
    Bedognetti, Davide
    Shen, Rhine R.
    Andrade, Jorge
    Filosto, Simone
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [48] CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist?
    Kuipers, Maria Theresa
    Kersten, Marie Jose
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [49] Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma
    Jessica J. Jalbert
    Ning Wu
    Chieh-I Chen
    Srikanth Ambati
    Wenzhen Ge
    Jon E. Arnason
    Advances in Therapy, 2022, 39 : 2630 - 2640
  • [50] Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study
    Zhai, Yinghong
    Hu, Fangyuan
    Zhu, Borui
    Xu, Jinfang
    Guo, Xiaojing
    Shi, Wentao
    Zhou, Xiang
    Zheng, Yi
    Xu, Xiao
    Ye, Xiaofei
    He, Jia
    Xu, Feng
    IMMUNOTHERAPY, 2023, 15 (06) : 443 - 456
12345